A new report dubbed "BrowserGate" warns that Microsoft's LinkedIn is using hidden JavaScript scripts on its website to scan ...
The recent explosion in artificial intelligence (AI) data centers has created a litany of environmental and cultural issues for Native people and Tribes across the so-called “United States.” This, in ...
Indiana Youth Institute releases KIDS COUNT data book summarizing latest trends in education, health
INDIANAPOLIS — The Indiana Youth Institute has shared its Indiana KIDS COUNT data book, highlighting the needs of Hoosier children. According to a news release, the data revealed that Indiana ranked ...
PORTLAND, Ore. — Gov. Tina Kotek on Thursday highlighted a new Portland State University report compiling last year's one-night homelessness count across the state of Oregon, marking out progress on ...
An Equinix data center in Ashburn, Virginia. Swollen with seemingly insatiable demand for computing power, the AI boom has birthed hundreds of unicorns out of thin air, minted dozens of billionaires ...
Going into this winter’s Christmas Bird Count, Anchorage organizers expected a subpar tally, given the unusually strong and cold winds roaring through the city on Dec. 14, the local area’s designated ...
Winners & losers: Qualcomm is expanding its Arm-based Windows laptop push with the Snapdragon X2 Plus lineup and is using new benchmark data to claim the chips can outperform current AMD and Intel ...
The deal for Intersect, a data center and energy developer, is set to help Google build out its infrastructure for artificial intelligence. By Eli Tan Reporting from Seattle Google has agreed to buy ...
All episodes of Pluribus are available to watch on Apple TV Plus, as the show has now wrapped its first season. There is more on the way with Pluribus season 2 already confirmed, but, while you wait, ...
Please provide your email address to receive an email when new articles are posted on . Azacitidine plus venetoclax significantly improved EFS compared with induction chemotherapy for certain patients ...
In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results